News
News
- Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function and Macular Carotenoid Changes Using Guardion’s Proprietary Lumega-Z® Formulation Compared to AREDS-2 Formulation
13:30 - GlobeNewswire - GSK says third quarter revenue fell 3% to £8.65B
13:11 - TeleTrader - ORBCOMM Announces Third Quarter 2020 Results
12:00 - GlobeNewswire - Teleflex Interventional Urology Expands Portfolio with Introduction of the UroLift® Advanced Tissue Control (ATC)™ System
11:30 - GlobeNewswire - Rolls-Royce plunges 65% as it prepares closures
10:01 - TeleTrader - UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta
10:00 - GlobeNewswire - Nova Resources proposes buying Kaz Minerals for £3B
09:05 - TeleTrader - DAX opens 230 points lower amid stimulus fears
09:05 - TeleTrader - Dupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms presented for the first time at scientific meetings
10/26/2020 / 13:00 - GlobeNewswire - Relievant Announces Positive 12-Month Intracept Effectiveness Study Results From Community Based Practices
10/22/2020 / 15:30 - GlobeNewswire
Real-time